116 related articles for article (PubMed ID: 12616493)
1. Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment.
Kerfoot SM; Lord SE; Bell RB; Gill V; Robbins SM; Kubes P
Eur J Immunol; 2003 Mar; 33(3):729-39. PubMed ID: 12616493
[TBL] [Abstract][Full Text] [Related]
2. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine in vascular biology: from basic research to clinical disease.
Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.
Fong AM; Robinson LA; Steeber DA; Tedder TF; Yoshie O; Imai T; Patel DD
J Exp Med; 1998 Oct; 188(8):1413-9. PubMed ID: 9782118
[TBL] [Abstract][Full Text] [Related]
6. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Imai T; Hieshima K; Haskell C; Baba M; Nagira M; Nishimura M; Kakizaki M; Takagi S; Nomiyama H; Schall TJ; Yoshie O
Cell; 1997 Nov; 91(4):521-30. PubMed ID: 9390561
[TBL] [Abstract][Full Text] [Related]
7. Modulation of atherogenesis by chemokines.
Boisvert WA
Trends Cardiovasc Med; 2004 May; 14(4):161-5. PubMed ID: 15177267
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
[TBL] [Abstract][Full Text] [Related]
9. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions.
Schäfer A; Schulz C; Fraccarollo D; Tas P; Leutke M; Eigenthaler M; Seidl S; Heider P; Ertl G; Massberg S; Bauersachs J
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):55-62. PubMed ID: 17082482
[TBL] [Abstract][Full Text] [Related]
10. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
Hasegawa M; Sato S; Echigo T; Hamaguchi Y; Yasui M; Takehara K
Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human.
Foussat A; Coulomb-L'Hermine A; Gosling J; Krzysiek R; Durand-Gasselin I; Schall T; Balian A; Richard Y; Galanaud P; Emilie D
Eur J Immunol; 2000 Jan; 30(1):87-97. PubMed ID: 10602030
[TBL] [Abstract][Full Text] [Related]
12. The CX3C chemokine fractalkine in allergic asthma and rhinitis.
Rimaniol AC; Till SJ; Garcia G; Capel F; Godot V; Balabanian K; Durand-Gasselin I; Varga EM; Simonneau G; Emilie D; Durham SR; Humbert M
J Allergy Clin Immunol; 2003 Dec; 112(6):1139-46. PubMed ID: 14657873
[TBL] [Abstract][Full Text] [Related]
13. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion.
Chakravorty SJ; Cockwell P; Girdlestone J; Brooks CJ; Savage CO
Clin Exp Immunol; 2002 Jul; 129(1):150-9. PubMed ID: 12100035
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
[TBL] [Abstract][Full Text] [Related]
16. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation.
Haskell CA; Cleary MD; Charo IF
J Biol Chem; 1999 Apr; 274(15):10053-8. PubMed ID: 10187784
[TBL] [Abstract][Full Text] [Related]
17. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.
Goda S; Imai T; Yoshie O; Yoneda O; Inoue H; Nagano Y; Okazaki T; Imai H; Bloom ET; Domae N; Umehara H
J Immunol; 2000 Apr; 164(8):4313-20. PubMed ID: 10754331
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine targeting with a receptor-mimicking peptide-amphiphile.
Kokkoli E; Kasinskas RW; Mardilovich A; Garg A
Biomacromolecules; 2005; 6(3):1272-9. PubMed ID: 15877342
[TBL] [Abstract][Full Text] [Related]
19. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
[TBL] [Abstract][Full Text] [Related]
20. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
